Biotech stocks trade on FDA trial phases. Phase 2 data often builds value, cash runway limits dilution, and Quantum BioPharma ...
Biotech firms are gaining major traction in 2026 due to the global pandemic. Take a look at some of the key features of ...
The stock market's attention has been focused almost exclusively on artificial intelligence, semiconductors and a handful of megacap technology companies. Investors looking for value may find one of ...
Unsecured, non-interest-bearing loan provides additional working capital supportWINNIPEG, Manitoba, Oct. 16, 2026 (GLOBE NEWSWIRE) -- (TSX-V:KNE) (the “Company”, “Kane” or “Kane Biotech”), a ...
Biotech stocks have reached their highest level since the height of the pandemic after Moderna (MRNA) and Merck (MRK) announced that a late-stage trial testing their messenger RNA-based cancer therapy ...
Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The ...
LB2501 is an off-the-shelf in vivo CAR-T therapy designed to generate dual-targeting CD19/CD20 CAR-T cells directly within ...
Biotech stocks are considered extremely high-risk, high-reward investments. Many biotech companies are developing one or more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results